- $7.12m
- -$9.18m
- $7.30m
- 37
- 70
- 58
- 55
Annual cashflow statement for Pulmatrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.6 | -19.3 | -20.2 | -18.8 | -14.1 |
| Depreciation | |||||
| Non-Cash Items | 9.92 | 11.3 | 5.8 | 2.5 | 2.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.7 | -4.67 | -5.53 | -3.18 | -4.3 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 3.23 | -12.5 | -19.7 | -19.4 | -16 |
| Capital Expenditures | -0.058 | -0.281 | -0.144 | -0.086 | -0.676 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.058 | -0.281 | -0.144 | -0.086 | -0.676 |
| Financing Cash Flow Items | 0 | — | — | -0.152 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.7 | 21 | 43.5 | 1.23 | 0.053 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 20.9 | 8.22 | 23.6 | -18.2 | -16.6 |